Machavert Pharmaceuticals reports progress in MP1000 cancer drug development

Machavert Pharmaceuticals reports progress in MP1000 cancer drug development

AURORA -- Machavert Pharmaceuticals , a drug development company focused on bioactive phospholipid therapeutics for the treatment of cancer, recently announced the progress of its MP1000... Read More

Monday November 26, 2018 0 comments Tags: Aurora, Machavert, Neal Goodwin, MP 1000